BSX Boston Scientific Corp stock chart & analysis
Conviction 57HealthcareScan · Fri, Nov 6, 2026Boston Scientific Corp (BSX) closed at $42.75 (-4.23%) on Nov 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 45, RS Rating 11, -59.5% from its 52-week high, -55.2% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
BSX technical analysis
Trend
BSX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 3.6% below the 50-day ($44.33) and 22.8% below the 200-day ($55.36). ADX(14) at 18 points to a weak trend — more range than direction. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 45, in the bearish half of its range. MACD crossed below its signal line on the latest session. Its RS Rating of 11 puts its weighted 12-month performance ahead of about 11% of the US market.
Volume and volatility
Volume on the latest session ran 0.5× its 20-day average. It trades about $884.1M a day on average. ATR(14) is $1.80, 4.2% of price — its typical daily range. A Bollinger Band squeeze just fired. Chaikin Money Flow (0.13) shows accumulation.
Key levels
The chart pattern's support is $40.48 and its resistance $46.57. The 52-week range is $39.57 to $105.65; price is 59.5% below the high and 8.0% above the low. The VWAP anchored at the 52-week high is $58.89, above price.
Performance
BSX returned +1.8% (1 week), +1.7% (1 month), -15.3% (3 months), -20.7% (6 months), -56.8% (1 year), -55.2% (year to date).
About Boston Scientific Corp
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Surgical & Medical Instruments & Apparatus · Listed 1992 · 59,000 employees
Recent news
- BOSTON SCIENTIFIC CORP: Ownership stake amendedSEC EDGAR · Fri, Nov 6, 2026
Congress activity
Disclosed STOCK Act trades in BSX · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Kevin Hern house · R · OK · traded 2026-09-09 | Sell | $50K–$100K | 2026-09-09 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-08-31 | Sell | $15K–$50K | 2026-08-31 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-09-04 | Sell | $50K–$100K | 2026-09-04 | 2026-09-25 | |
Kevin Hern house · R · OK · traded 2026-09-03 | Sell | $1K–$15K | 2026-09-03 | 2026-09-25 | |
 Gilbert Cisneros house · D · CA · traded 2026-08-18 | Buy | $1K–$15K | 2026-08-18 | 2026-09-10 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 John Boozman senate · R · AR · traded 2026-06-04 | Sell | $1K–$15K | 2026-06-04 | 2026-07-13 | |
Gilbert Cisneros house · D · CA · traded 2026-06-05 | Buy | $1K–$15K | 2026-06-05 | 2026-07-02 | |
Gilbert Cisneros house · CA · traded 2026-05-11 | Buy | $1K–$15K | 2026-05-11 | 2026-06-05 | |
Gilbert Cisneros house · CA · traded 2026-05-19 | Buy | $1K–$15K | 2026-05-19 | 2026-06-05 |
Insider activity
SEC Form 4 transactions in BSX · open-market 3 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mahoney Michael F Chairman, President & CEO · Common Stock · 2026-11-04 | Gift | 149.99K | — | 2026-11-04 | 2026-11-06 |
Mahoney Michael F Chairman, President & CEO · Common Stock · 2026-11-04 | Gift | 102.25K | — | 2026-11-04 | 2026-11-06 |
O'Sullivan Miriam SVP, Chief HR Officer · Common Stock · 2026-11-01 | Exercise | 3.87K | — | 2026-11-01 | 2026-11-03 |
O'Sullivan Miriam SVP, Chief HR Officer · Common Stock · 2026-11-01 | Tax | 1.87K | $79K | 2026-11-01 | 2026-11-03 |
O'Sullivan Miriam SVP, Chief HR Officer · Restricted Stock Units · 2026-11-01 | Exercise | 3.87K | — | 2026-11-01 | 2026-11-03 |
Morano Susan E Director · Common Stock · 2026-08-25 | Buy | 2.04K | $100K | 2026-08-25 | 2026-08-26 |
Woodworth Emily SVP, Global Controller and CAO · Common Stock · 2026-08-11 | Acquire | 2.93K | $150K | 2026-08-11 | 2026-08-12 |
Monson Jonathan EVP and CFO · Common Stock · 2026-08-10 | Acquire | 9.91K | $500K | 2026-08-10 | 2026-08-11 |
Habiger David C Director · Common Stock · 2026-08-05 | Buy | 2.1K | $100K | 2026-08-05 | 2026-08-07 |
Habiger David C Director · Common Stock · 2026-08-04 | Buy | 140 | $7K | 2026-08-04 | 2026-08-05 |
SEC filings
EDGAR filings in BSX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.